| | A Phase 3 Study to Evaluate Zimberelimab (AB122) Combined with Domvanalimab (AB154) Compared to Pembrolizumab in Front-Line, PD-L1-High, Locally Advanced or Metastatic Non‑Small Cell Lung Cancer . . . |
Ongoing |
01 Mar 2023 |
| | A Phase 3 Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. . . . |
Ongoing |
07 Oct 2021 |
| | A Phase 3, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-controlled Sequential Dose Titration Study to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Pediatric Subjec . . . |
Ongoing |
31 May 2023 |
| | A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine an . . . |
Terminated |
03 Jul 2020 |
| | A phase 3, multicenter, four-week, randomized, double-blind, placebo-controlled, parallel-group efficacy and safety trial of flexible doses of oral ziprasidone in children and adolescents with bipolar . . . |
Terminated |
27 Aug 2020 |
| | A Phase 3, Multicenter, Long-Term Observational Study Of Subjects From Tanezumab Studies Who Undergo A Total Knee, Hip or Shoulder Replacement . . . |
Completed |
17 Jul 2019 |
| | A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreate . . . |
Ongoing |
22 Sep 2022 |
| | A Phase 3, Open Label, Multicenter, Baseline-Controlled Sequential Dose Titration Study Followed by a Fixed Dose Observation Period to Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prol . . . |
Pending |
18 Dec 2022 |
| | A Phase 3, Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy And Safety Of FG-4592 For The Treatment Of Anemia In Chronic Kidney Disease Patients Not On Dialysis . . . |
Completed |
02 Aug 2019 |
| | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab plus Standard of Care versus Placebo plus Standard of Care in Adult Subjects with Active . . . |
Completed |
12 Aug 2021 |
| | A Phase 3, Randomized, Multicenter, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Pegcetacoplan (APL-2) in Patients with Paroxysmal Nocturnal Hemoglubinuria (PNH) . . . |
Completed |
06 May 2022 |
| | A Phase 3, Randomized, Multicenter, Placebo-controlled, Double-blind Clinical Study of the Safety and Efficacy of Carrimycin for Treatment of Severe COVID-19 in Hospitalized Patients . . . |
Terminated |
23 Sep 2022 |
| | A Phase 3, randomized, stratified, observer-blind, active-controlled study to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults 18 years and older . . . |
Ongoing |
30 Nov -0001 |
| | A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compar . . . |
Pending |
30 Nov -0001 |
| | A Phase Ib Multicenter, Open-label Dose-escalation Study to Evaluate the Safety and Tolerability of Trastuzumab Deruxtecan(T-DXd) and Durvalumab in Combination with Cisplatin, Carboplatin or Pemetrexe . . . |
Ongoing |
30 Nov -0001 |
| | A Phase II, double-blind, controlled trial to assess the Safety and Immunogenicity of different schedules of Takeda’s Tetravalent Dengue Vaccine Candidate (TDV) in healthy subjects aged between 2 an . . . |
Completed |
13 Apr 2020 |
| | A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus and in Cutaneous Lup . . . |
Ongoing |
20 May 2022 |
| | A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with . . . |
Ongoing |
16 Feb 2023 |
| | A Phase II/III, Multicenter, Observer- Blinded, Randomized, Non-inferiority and Safety Study of Typhoid Conjugate Vaccine (EuTCV) Compared to Typar- TCV ® in Healthy 6 Months – 45 Years Aged Partic . . . |
Completed |
03 Nov 2021 |
| | A Phase II/III, Randomized, Double-blinded Study to Evaluate the Efficacy, Safety and Immunogenicity of a Booster Dose of PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Ad . . . |
Ongoing |
23 Feb 2023 |
| | A Phase II/III, Randomized, Double-blinded Study to Evaluate the Efficacy, Safety and Immunogenicity of a Booster Dose of PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Ad . . . |
Ongoing |
23 Feb 2023 |
| | A phase IIb /III clinical study to evaluate the safety and immunogenicity of the Recombinant COVID-19 Variant Vaccine (Sf9 cell) in adults aged 18 years and above as heterologous booster vaccination . . . |
Suspended |
02 May 2023 |
| | A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα- Kinoid in Adult Subjects with System . . . |
Terminated |
30 Apr 2021 |
| | A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, . . . |
Ongoing |
19 May 2020 |
| | A Phase III double-blind study to assess safety andefficacy of an RSV Maternal unadjuvanted vaccine,in pregnant women and infants born to vaccinatedmothers . . . |
Ongoing |
03 Aug 2021 |